학술논문

Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial
Document Type
Article
Source
In: The Lancet Gastroenterology and Hepatology. (The Lancet Gastroenterology and Hepatology, April 2024, 9(4):333-345)
Subject
Language
English
ISSN
24681253